Experimental study of the killing effect of proteasome inhibitor MG132 on gallbladder cancer cells

Wei-ping ZHU,Di-hua ZHAN,Yi-ming ZHAO,Lu Wang,Hong-wei Xie,Hui-peng Wang,Zhi-jian Cheng
DOI: https://doi.org/10.11952/j.issn.1007-1954.2016.02.008
2016-01-01
Abstract:objective To investigate the mechanism of proteasome inhibitor MG132 in inhibiting prolifera-tion and inducing apoptosis of gallbladder cancer cells. Methods The anti-tumor activity of MG132 on gallblad-der cancer cells was assessed by the CCK8 assay. Apoptosis changes were detected by flow cytometric analysis. The protein and mRNA expression of Caspase-8, Caspase-3 and DR5 were examined using Western blotting and RT-PCR. Gallbladder cancer xenografts in athymic nude mice were established and the tumor weight and volume were measured after the intervention of MG132. Results The results showed that MG132 inhibited the prolifera-tion of gallbladder cancer cells in a dose-dependent manner both in vivo and in vitro (P<0.01). Exposure of tumor cells to MG132 induced cell cycle arrest at G2/M phase and apoptosis in a dose- dependent manner (P<0.01). In addition, analysis of apoptotic pathways indicated that MG132 significantly enhanced the activation of Caspase-8, Caspase-3 and DR5 in extrinsic signaling pathway (P<0.05). Conclusion Proteasome inhibitor MG132 can ef-fectively kill gallbladder cancer cells and its mechanism involves the cell cycle arrest and apoptosis induction.
What problem does this paper attempt to address?